Endoscopic fluorescence spectroscopy in the upper GI tract for the detection of GI cancer: Initial experience

Department of Medicine I, University of Erlangen-Nuremberg, Erlangen, Germany.
The American Journal of Gastroenterology (Impact Factor: 10.76). 10/2001; 96(9):2616-21. DOI: 10.1111/j.1572-0241.2001.04122.x
Source: PubMed


The aim of this study was to investigate autofluorescence spectroscopy using violet-blue excitation light for the in vivo diagnosis of GI cancer during routine endoscopy.
Fluorescence spectra were obtained from normal mucosa and cancerous lesions of the esophagus and stomach. The spectroscopic system used comprised a special light source capable of delivering either white or violet-blue light to induce autofluorescence of tissue via the endoscope. Endogenous fluorescence spectra emitted by the tissue were recorded with a fiberoptic probe and analyzed with a spectrographic detector system consisting of a polychromator with a photodiode array and an optical multichannel analyzer. The data of each spectrum were sampled within the range of 450-700 nm and stored in a personal computer.
Esophageal squamous cell cancer, adenocarcinoma of the esophagus, and adenocarcinoma of the stomach show specific differences in the emitted fluorescence spectra compared with normal mucosa.
Light-induced fluorescence spectroscopy might be a useful tool for the endoscopic in vivo detection of dysplasia and early carcinoma in the upper GI tract. Further trials are needed to test the validity of this new optical detection system.

  • Source
    • "Recent study has shown that the optical properties (absorption and scattering) of human tissue are closely related to some of the key diagnostic physiological parameters, which would significantly vary with its exact disease state [2] [3] [4] [5] [6] [7] [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we report the design, fabrication and testing of a new miniaturized optical sensor probe with “side viewing” capability for oblique incidence diffuse reflectance spectrometry. The sensor probe consists of a lithographically patterned polymer waveguides chip and two micromachined positioning substrates and source/collection fibers to achieve 45° light incidence and collection of spatially resolved diffuse reflectance. Diffuse reflectance of human esophageal surface has been successfully measured for differentiation of cancerous tissues from normal ones.
    Preview · Article · Mar 2009 · Sensors and Actuators A Physical
  • Source
    • "Even a coarse needle biopsy, which is tipically more accurate than an FNA, cannot always provide an answer since it is only able to distingiush a follicular neoplasm (which include both adenoma and cancer) versus nontoxic nodular gotier in about 40% of the cases. This difficulty in diagnosis is one of the most frustrating topics for physicians involved in the thyroid study, because it means that surgery is often the only way of definitively diagnosing a thyroid nodule, determining unnecessary damages to a number of patients [5] [6] [8]. Consequently any new method allowing a more accurate diagnosis of the follicular cancer would be welcome. "
    [Show abstract] [Hide abstract]
    ABSTRACT: An autofluorescence analysis has been performed on healthy as well as tumour thyroid tissue samples to distinguish follicular cancer from normal thyroid. Complete spectra and synchronous spectra have been recordered from properly stored samples. Fluorescence bands located at 350 nm and 400 nm has been observed in the analysed cancer samples.
    Full-text · Article · Jan 2005 · Spectroscopy
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: L’existence d’effets secondaires dans les traitements de la médecine moderne constitue actuellement l’une des principales préoccupations du grand public. La mise au point de thérapies ciblant spécifiquement les cellules malades représente l’un des challenges de la lutte contre le cancer. Mis à part quelques exceptions, la plupart des thérapies anticancéreuses ne permettent pas d’éradiquer véritablement la maladie, on parle plutôt de période de rémission qui ne font qu’allonger la durée de vie des patients. La thérapie photodynamique (PDT) ciblant l’acide-δ-aminolevulinic (ALA) représente une méthode pour le traitement du cancer. ALA est une molécule naturellement présente dans nos cellules, elle est à l’origine de la biosynthèse de l’hème, un constituant des globules rouges. Dans le cas des cellules cancéreuses, ce mécanisme est perturbé et conduit à l’accumulation d’un composé intermédiaire Protoporphyrine (PpIX) qui a la particularité d’être photosensible et fluorescent. Par conséquent l’utilisation d’ALA comme ‘prodrogue’ conduit à une surproduction de ce composé photosensible au sein des cellules malades et permet leurs détection ainsi que leurs traitement. De nouvelles ‘prodrogues’ plus sélectives que ALA sont cependant nécessaires. Nous avons donc synthétisé des dérivés où une molécule d’ALA est connectée à différentes biomolécules, comme des glucides, des acides aminés, des glycérols ou encore des vitamines. Tous les produits synthétisés ont été testés sur différents types de cellules cancéreuses, les dérivés ALA-glucide se sont révélés particulièrement efficaces et non cytotoxiques. En effet certains d’entre eux induisent une production plus importante de composés photosensibles que ALA et de plus ils s’avèrent très sélectifs envers certains types de cellules cancéreuses. Ce travail de thèse a finalement permis la synthèse d’une nouvelle variété de prodrogues plus efficaces que celle disponible sur le marché (ALA), contribuant à la détection des cellules cancéreuses et dans certains cas à leur élimination. One of the concerns of the general public about modern day medicine is ‘side effects’. Therapies targeting only the diseased cells are the solution for this. The targeted delivery of drugs is one of the main challenges that all cancer therapies are dealing with. With very few exceptions, almost all the therapies for cancer today are only extending the life of patients by few months instead of really targeting cancer cells and cure patients. Delta aminolevulinic acid (or 5-aminolevulinic acid or shortly ALA) based photodynamic therapy (PDT) is one among the therapies for cancer. ALA is a natural product which is synthesized in the body of all human beings which transforms in series of steps to heme. One of the intermediates in heme pathway is Protoporphyrin IX (PpIX) which is a photosensitizer. ALA, when administered externally induces preferentially higher PpIX production in cancer cells. The fluorescent nature of PpIX is used for detection of cancer cells besides therapy. Novel prodrugs for inducing higher PpIX generation than ALA and having more selectivity towards cancer cells are required. We synthesized novel derivatives of ALA where ALA is conjugated with monosaccharides (sugars), natural alcohols, vitamins and aminoacids. Also derivatives of porphobilinogen (PBG) which is an advanced intermediate in heme pathway were synthesized. We synthesized different ALA-sugar derivatives where not only different sugars were utilized for conjugation, but also, ALA was substituted in different hydroxyl groups of sugars. All the novel prodrugs were evaluated for PpIX induction using various cancer cell lines. We found that all these novel prodrugs are not cytotoxic; some of them induce higher generation of PpIX than ALA. But the selectivity towards cancer cells is not better than ALA.
    Preview · Article ·
Show more